Stock MPH MEDICURE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Medicure Inc.

Equities

MPH

CA58469E4085

Market Closed - Toronto S.E.
Other stock markets
 16:32:40 21/06/2024 BST 		5-day change 1st Jan Change
1.02 CAD -6.42% Intraday chart for Medicure Inc. -4.67% -27.14%
05-29 Transcript : Medicure Inc., Q1 2024 Earnings Call, May 29, 2024
05-28 Medicure Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medicure Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Medicure Inc. Appoints Kimberly Kramchynsky, Known as Kim Kline as Director
Medicure Swung to a Loss in 2023 on Lower Sales
Medicure Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Marley Drug Announces A Partnership with TheracosBio to Distribute A Newly Approved Diabetes Drug, BRENZAVVY
Medicure Inc. Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
Medicure Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Medicure Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medicure's Q1 Profit, Revenue Falls; Up Nearly 13%
Medicure's Q1 Profit, Revenue Falls
Medicure Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medicure Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Medicure Inc. Announces Resignation of Gerald McDole as Member of the Board of Directors
Medicure Reports Q3 2022 Net Income of $1.1 Million, Total Net Revenue of $5.3 Million
Medicure Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Medicure Seeks Acquisitions
Medicure Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medicure Second-Quarter Loss Widens on Higher Research and Development Spending
Medicure Inc. Appoints James Kinley as Director
Medicure Reports Q1 EPS of $0.05, Appoints Haaris Uddin As CFO
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MPH Stock
  4. News Medicure Inc.
  5. Other languages